Francesca Vannuccini

Vericiguat in patients with chronic heart failure and reduced ejection fraction (VICTOR): a double-blind, placebo-controlled, randomised, phase 3 trial

Javed Butler, Ciaran J. McMullan, Kevin J. Anstrom et al. · The Lancet · 2025 · 29 citations · Full text

Supraventricular tachycardias in the first year of life: what is the best pharmacological treatment? 24 years of experience in a single centre

Guglielmo Capponi, Gilda Belli, Mattia Giovannini et al. · BMC Cardiovascular Disorders · 2021 · 14 citations · Full text

Myocardial work and left heart deformation parameters across primary mitral regurgitation severity

Maria Concetta Pastore, Francesca Vannuccini, Giulia Elena Mandoli et al. · International Journal of Cardiology · 2024 · 14 citations · Full text

Vericiguat for patients with heart failure and reduced ejection fraction across the risk spectrum: an individual participant data analysis of the VICTORIA and VICTOR trials

Faı̈ez Zannad, Christopher M. O’Connor, Javed Butler et al. · The Lancet · 2025 · 14 citations · Full text

Effect of sacubitril/valsartan on cardiac remodeling compared with other renin–angiotensin system inhibitors: a difference-in-difference analysis of propensity-score matched samples

Erberto Carluccio, Frank Lloyd Dini, Michele Correale et al. · Clinical Research in Cardiology · 2023 · 12 citations · Full text